HopeStage
Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
More filters: keywords, city, remote
274studies shown
Showing 181-192 of 274
Drug study icon
CompletedNCT00307684

Safety study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in ADHD

What is this study about?

Researchers compared open label PR OROS methylphenidate, double blind PR OROS methylphenidate and placebo, tracking side effects to assess long-term safety and tolerability in adults with ADHD.

This study has finished and is no longer accepting participants.

In Switzerland
ADHDMedication studyAges 18–65
Countries
Switzerland, France, Germany, + 4 others
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedNCT01281527

Paliperidone Palmitate Flexible Dosing in Schizophrenia

What is this study about?

Researchers studied Paliperidone Palmitate to find out how it affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

In Switzerland
SchizophreniaMedication studyAges 18+
Countries
Switzerland, France, United Kingdom, + 17 others
Sponsor
Janssen-Cilag International NV
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.